Home | Repositories | Statistics | About





Year: 2019


Type: Article



Title: Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial


Author: Welsh, Robert C
Author: Sidhu, Robinder S
Author: Cairns, John A
Author: Lavi, Shahar
Author: Kedev Sasko
Author: Moreno, Raul
Author: Cantor, Warren J
Author: Stankovic, Goran
Author: Meeks, Brandi
Author: Yuan, Fei
Author: Džavík, Vladimír
Author: Jolly, Sanjit S



Abstract: Robust comparisons between oral P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) in ST-elevation myocardial infarction (STEMI) patients who undergo primary percutaneous coronary intervention are lacking. We sought to evaluate outcomes on the basis of P2Y12 inhibitor therapy in patients from the Thrombectomy With PCI Versus PCI Alone in Patients With STEMI Undergoing Primary PCI (TOTAL) trial.


Publisher: Elsevier BV


Relation: The Canadian journal of cardiology



Identifier: oai:repository.ukim.mk:20.500.12188/9011
Identifier: http://hdl.handle.net/20.500.12188/9011
Identifier: 10.1016/j.cjca.2019.04.026
Identifier: https://api.elsevier.com/content/article/PII:S0828282X19303009?httpAccept=text/xml
Identifier: https://api.elsevier.com/content/article/PII:S0828282X19303009?httpAccept=text/plain
Identifier: 35
Identifier: 10



TitleDateViews
Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial201936